• linkedin
  • Increase Font
  • Sharebar

    Hidradenitis Suppurativa therapy options progressing

    Early recognition and treatment can prevent disease progression, improve prognosis


    Lasers blaze new trails

    Recently, the use of light-based therapies has been shown to significantly improve lesions of hidradenitis. According to Dr. Hazen, Iltefat Hamzavi, M.D., at Henry Ford Hospital in Detroit has reported that the neodymium YAG laser has been able to reduce the number and intensities of inflammatory lesions in patients with all stages of hidradenitis. The carbon dioxide laser has also been useful, when used in either a vaporization or excisional mode.

    READ: Laser technology creates hi-res maps of acne lesions

    “We have had significant success, with much lower rates of recurrence, in removing large or small abscesses and sinus tracts using the CO2 laser to facilitate the removal of persistent lesions of HS,” Dr. Hazen says.

    Factors determining the surgical success of all therapies appear to relate to the goal of either removing or ablating the abscesses and tunnels/sinus tracts. When surgical removal has been performed, healing by secondary intention appears to create less risk of recurrence.

    “If one sees a patient with a persistent inflammatory lesion, whether it be small or cavitary, and particularly if there is tunneling that takes place with scar formation, he or she should be recognized to likely have the qualities suggestive of HS rather than a single infectious event,” Dr. Hazen says. “Treating patients early and bringing their inflammation under control can help in stemming the disease process and its progression, potentially resulting in a more favorable prognosis.”

    The past three years have seen great strides in managing all facets of HS, Dr. Hazen says, including recognition, patient and physician education, research, and medical and surgical therapies. Hopefully this will give great encouragement to the millions of people affected by this condition.


    Dr. Hazen has provided consulting services for Abbvie.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow